Feedback Share Discussion Threads

[lr2] 28/4/2015 10:01

That's true Davy, it is difficult to ascertain profitability. I've had to take the very limited sales information up to the date of the last interim report and attempt to deduce the sales revenue divided by number of sales to get an average sale price. I then had to scour the internet in an attempt to find any sales revenue mentioned for the more recent sales going forward (I only found a single mention by the way). So, I apologise for my enthusiasm and will adjust my previous post to add 'in my opinion' at the end of it. I would not want people to assume I am correct in my assumption. It is, after all, just my assumption and as is so often heard, a person should always do their own research.

[davydoo] 28/4/2015 09:49

LR2 how can you imply from profitability from these RNSs?

There is scant reference to sales value, and we know that they have added costs with additional staff

[lr2] 28/4/2015 09:30

There's little doubt in my mind that the 'No Reason' RNS was forced upon the company by the Nomad.

The hint that the company did not agree with it was there for all to see.

"The Company remains in active discussions with potential customers for its medical imaging software."

I added to my holding once the RNS was released. The new deals we are now seeing should make FDBK profitable from this point onwards in my opinion.

[21trader] 28/4/2015 09:23

So no reason for the rise and they have announced 4 Rns's in 2 weeks infact
they cannot stop issuing news now.

What they going to do later when the price hits the same level, well it's at that
level now where they said no reason for the rise, issue it again ?

Not impressed.

[sja123] 28/4/2015 09:12

Bought in here yesterday....the software seems to be gaining more traction in more geographies daily...

I wonder when we will hear on FDA approval....they seem to have been working on that for a while now and you would assume it would be easier to obtain for a diagnostic tool....

[hamidahamida] 28/4/2015 08:09

Market Cap only £4 Million Massively underpriced with all these deals it's matter of time before this shoots up

[blueball] 28/4/2015 07:35

Another RNS.

[wantage] 27/4/2015 20:15

Before Tom Charlton blew himself out investing in Feedback, he was right up there at Mercury, and Merrill Lynch.I would guess he's taken a great deal of trouble finding the right come back vehicle.Maybe this time he'll get it right, and so will we.

[hamidahamida] 27/4/2015 16:58

Siemens was OEM guys who sold the texRAD software to this prestigious Korean hospital revealed by Dr. Balaji Ganeshan in a interview with Zak Mir A lot more news to come out by the looks of it exciting times ahead. MARKET CAP ONLY @ £4million

[blueball] 27/4/2015 16:51

First time Feedback have worked with the big boys.

start of a long journey.

[the stigologist] 27/4/2015 16:42

so the company are paying tiptv to be allowed to ramp the shares

placing imminent

[kenwrong] 27/4/2015 16:19

Just added todays TipTV interview with Dr Ganeshan of Feedback to Traders Own. He talks about the recent announcements and the increased activity in the shares with Zak Mir. hxxp://tradersown.co.uk/company/278409/FeedbackPLC

[lr2] 27/4/2015 13:51

Not for much longer with a little bit of luck.



In my youth, I lived in Iran for a short while. Broke my foot whilst there and I have to say, the medical treatment was first class.

Tight spread at the moment - 2.11p - 2.15p.

[wantage] 27/4/2015 13:44

I've heard via another medical supply company that it's virtually impossible
getting paid from Iran due to sanctions.

[lr2] 27/4/2015 12:53

Iran - Kooy is an area of Tehran where the country's University of Medical Sciences is based.

[wantage] 27/4/2015 12:45

Where was this article in Arabic published? Presumably there's a big promotion going on in the middle east?

[lr2] 27/4/2015 10:38

Just a little heads up on the current trades.

It may look like there's a number of sellers around the 2.2p mark but they aren't.

The current quote is 2.1p to sell and 2.192p to buy (rising on quantity to 2.22p).

The last 8 trades shown are buys not sells in my opinion.

[the stigologist] 27/4/2015 09:06

run rate annual losses look like about A MILLION

[the stigologist] 27/4/2015 08:55

dont mention the low price they sell the software for

or the limited revenues

or the huge losses

[hamidahamida] 27/4/2015 08:49

Just 4million market cap for a company that's signing these Prestigious hospitals around the world along with NHS hospitals for this patented ground breaking Cancer analyse software that is helping sufferers get the right treatment and cut bills for the hospitals.They are planing to launch commercial version of this software for the pharmaceutical sector in 2/3 quarter. IMHO Market cap should be 40/50 million (20+p) for a company that is involved in helping patients get the right Cancer treatment the very first time.